These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6579938)

  • 41. Clinical pharmacology of amiodarone.
    Marcus FI
    Ann N Y Acad Sci; 1984; 427():112-26. PubMed ID: 6378011
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
    Sheinman BD; Evans T
    Br Med J (Clin Res Ed); 1982 Oct; 285(6347):999-1000. PubMed ID: 6812745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
    Ward DE; Camm AJ; Spurrell RA
    Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias.
    Mostow ND; Rakita L; Vrobel TR; Noon D; Blumer J
    J Am Coll Cardiol; 1984 Jul; 4(1):97-104. PubMed ID: 6736461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Life-threatening ventricular arrhythmias provoked by amiodarone treatment.
    Kumana CR; Tanser P; Eydt J
    Hum Toxicol; 1985 Mar; 4(2):169-76. PubMed ID: 4007880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
    Tuzcu EM; Gilbo J; Masterson M; Maloney JD
    Cleve Clin J Med; 1989 May; 56(3):238-42. PubMed ID: 2743545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
    Shahar E; Barzilay Z; Frand M; Feigl A
    Pediatrics; 1983 Dec; 72(6):813-6. PubMed ID: 6646922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.
    Ochi RP; Goldenberg IF; Almquist A; Pritzker M; Milstein S; Pedersen W; Gobel FL; Benditt DG
    Am J Cardiol; 1989 Sep; 64(10):599-603. PubMed ID: 2782249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Amiodarone in the nineties: to whom and what dosage?].
    Moro Serrano C; Hernández Madrid A; Lage Silveira J; Vivas Alvarez E; Kanjhi M
    Rev Esp Cardiol; 1995 Apr; 48(4):272-84. PubMed ID: 7740149
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
    Rasmussen V; Berning J
    Acta Med Scand; 1979; 205(1-2):31-7. PubMed ID: 367085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.